Neither intensive blood pressure control nor intensive lipid management slowed cognitive decline in adults with long-standing type 2 diabetes.
Additionally, after 40 months, patients in the ACCORD...
ATLANTA – It’s too soon to disrupt current obesity treatment by declaring food addiction to be a clinical condition, according to Dr. Paul Fletcher.
"If we are to employ [the term] food...
An incentivized, system-based approach to improve care for patients with diabetes and other chronic diseases appeared to pay off after just 3 years by significantly cutting the incidence of adverse...
Researchers have identified two novel panels of microRNAs that eventually might be used to screen patients for pancreatic cancer, distinguishing affected patients from healthy individuals and from...
Mortality is not lower among adults with diabetes who were overweight or obese at diagnosis than among those who were of normal weight, as has been suggested by proponents of the "obesity...
Dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, has been approved for the treatment of type 2 diabetes with a requirement that the manufacturer conduct postmarketing studies that address...
WASHINGTON – The rise in gestational diabetes cases demands new strategies for active postpartum care that will not only assist with prevention of type 2 diabetes, but will also prepare women for...
